Suwon-si, South Korea

Jang Seong Kim


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Suwon-si, KR (2004 - 2006)
  • Suwon, KR (2010)

Company Filing History:


Years Active: 2004-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Jang Seong Kim

Introduction

Jang Seong Kim is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins and therapeutic agents. With a total of three patents to his name, his work focuses on immunologically active proteins and angiogenesis inhibitors.

Latest Patents

One of his latest patents involves detoxified and immunologically active proteins known as 'mutant LTs'. These proteins have mutated amino acid sequences of heat-labile enterotoxin and are designed for use as immunogenic antigens for vaccination. Unlike wild-type LT, the mutant LTs do not induce toxic activities, making them promising candidates for developing a novel diarrheal vaccine in humans and animals. Additionally, they may be effective in preventing and treating various diseases by enhancing antibody production.

Another significant patent by Jang Seong Kim is for a novel angiogenesis inhibitor named LK68. This protein is identical to the human apolipoprotein (a) kringle domains and has shown potential as an anticancer agent. LK68 inhibits endothelial cell proliferation and migration, demonstrating effectiveness in suppressing tumor-induced angiogenesis. This innovation could lead to advancements in treating angiogenesis-mediated diseases, including cancer and rheumatoid arthritis.

Career Highlights

Jang Seong Kim is affiliated with the Mogam Biotechnology Research Institute, where he continues to conduct research and develop innovative solutions in biotechnology. His work has garnered attention for its potential applications in medicine and public health.

Collaborations

Some of his notable coworkers include Jihoon Chang and Eun Jeong Park, who contribute to the collaborative efforts at the Mogam Biotechnology Research Institute.

Conclusion

Jang Seong Kim's innovative work in the field of biotechnology highlights the importance of research in developing new therapeutic agents. His contributions have the potential to significantly impact public health and advance medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…